Keros Therapeutics
KROS
#6680
Rank
$0.67 B
Marketcap
$22.12
Share price
2.01%
Change (1 day)
-67.05%
Change (1 year)

Keros Therapeutics (KROS) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : $39.2 Million USD

According to Keros Therapeutics's latest financial reports the company's total liabilities are $39.2 Million USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Keros Therapeutics - Total liabilities on balance sheet (from 2019 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31$44.33 M17.25%
2023-12-31$37.81 M28.8%
2022-12-31$29.35 M143.09%
2021-12-31$12.07 M56.4%
2020-12-31$7.72 M-26.18%
2019-12-31$10.46 M-28.62%
2018-12-31$14.65 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ORIC Pharmaceuticals
ORIC
$24.27 M-38.08%๐Ÿ‡บ๐Ÿ‡ธ USA